Somasundaram Subramaniam, MD MS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Exelixis
    Topic:
    Cabozantinib
    Date added:
    08/19/2022
    Date updated:
    08/19/2022
Return to 2022 Seattle Multidisciplinary Thoracic Oncology Conference